Skip to main content
ReviewedDiagnosis

Genetic Testing for Primary Ciliary Dyskinesia

Key takeaway

Genetic testing supports but does not replace nasal nitric oxide and ciliary biopsy; a negative result does not rule out PCD.
Laboratory technician reviewing a genetic sequencing report

How genetic testing complements nasal nitric oxide and ciliary biopsy in confirming a PCD diagnosis, and what a result can and cannot tell a family.

Why genetics matters in PCD

Primary ciliary dyskinesia is caused by pathogenic variants in one of more than 50 genes that build or maintain the motile cilia lining the airways, sinuses, middle ear and, in some patients, the structures that determine left-right body asymmetry.

A confirmed genetic diagnosis can end a long diagnostic journey, guide genetic counselling for the wider family, and in some cases point toward gene-specific clinical trials.

How the test is done

A blood or saliva sample is sent for a targeted gene panel or whole-exome sequencing covering the known PCD genes. Turnaround is typically several weeks.

Panels are usually read alongside nasal nitric oxide measurement and, where available, high-speed video microscopy or transmission electron microscopy of a nasal or bronchial ciliary biopsy, because no single test is sensitive enough on its own.

Common gene groups and typical ciliary findings

A small selection of the genes most frequently implicated, for illustration only.

Gene groupTypical ultrastructural finding
DNAH5, DNAI1Outer dynein arm defects
CCDC39, CCDC40Microtubular disorganisation
RSPH1, RSPH4ACentral pair/radial spoke defects

If a variant is found

A positive result is usually reviewed with a clinical geneticist, who can explain inheritance pattern (most PCD genes are autosomal recessive), recurrence risk for future pregnancies, and whether relatives may wish to be tested.

Diagnostic pathway

What genetic testing cannot tell you

  • A negative panel does not rule out PCD, since not every causative gene has been identified yet.
  • Genetic results alone do not predict day-to-day disease severity, which varies even between siblings with the same variant.
  • Testing does not replace the need for ongoing monitoring of lung function and hearing.

Medical review

Reviewed by
Dr. Elena Marsh, Clinical Geneticist
Last verified
June 2, 2026
Review due
June 2, 2027

Locale review

EN
Verified
ES
Verified
RU
In progress

Sources & evidence

  1. European Respiratory Society, PCD diagnostic guideline
  2. PCD Foundation, genetics of PCD patient guide
  3. Genetic and Rare Diseases Information Center (GARD)